Zinplava (Bezlotoxumab)

Zinplava is a human monoclonal antibody.  Bezlotoxumab works by binding to a specific toxin produced by the Clostridium difficile bacteria, to help neutralize the toxin’s effects in patients 18 years or older.

Zinplava is used together with antibiotic medicine in adults with Clostridium difficile (C. difficile), an infection that can cause life-threatening diarrhea.  Bezlotoxumab may help keep this infection from coming back after treatment.

Drug manufacturer information for Actemera is available here.